Health-related quality of life (HRQoL) in patients with diffuse large B-cell lymphoma (DLBCL) treated with polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin and prednisone (Pola-R-CHP) versus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) in the phase III POLARIX study Meeting Abstract
| Authors: | Friedberg, J. W.; Thompson, C. A.; Trněný, M.; Morschhauser, F.; Salles, G.; Reagan, P. M.; Hertzberg, M.; Smolewski, P.; Zhang, H.; Thieblemont, C.; Hu, B.; Fonseca, G.; Kim, W. S.; Martelli, M.; Mehta, A.; Campinha-Bacote, A.; Yan, M. R.; Hirata, J.; Sugidono, M.; Lee, C.; Sharman, J. P. |
| Abstract Title: | Health-related quality of life (HRQoL) in patients with diffuse large B-cell lymphoma (DLBCL) treated with polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin and prednisone (Pola-R-CHP) versus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) in the phase III POLARIX study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 6623 |
| End Page: | 6626 |
| Language: | English |
| ACCESSION: | WOS:000893223206285 |
| DOI: | 10.1182/blood-2022-157761 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
